Author: Sleep Review Staff

FDA Deepens Review of New Insomnia Drug

Based on a request from the Food and Drug Administration (FDA), Somaxon Pharmaceuticals, San Diego, is updating information regarding the preclinical testing of SILENOR™, a drug candidate for the treatment of insomnia.

Read More

New Data Support Long-Term Use of AMBIEN CR

A new study of AMBIEN CR, a controlled-release formula prescription sleep medication approved by the Food and Drug Administration (FDA) for sleep maintenance and sleep induction, found that the drug demonstrated significant improvements in total sleep time (TST), sleep onset latency (SOL), wake time after sleep onset (WASO), sleep quality, and number of awakenings versus placebo.

Read More